By Shelley Blas
May 31, 2012 – A motion was filed late last night in the product liability case involving Pradaxa.
The petition seeks transfer of nearly a dozen pending cases, and all future claims, to a centralized docket in the U.S. District Court for the Southern District of Illinois. If granted, this will coordinate all federal cases involving this drug.
Pradaxa is prescribed to prevent the formation of blood clots reducing the risk of strokes. However, it has been linked to serious and sometimes fatal bleeding. See article: Pradaxa named in most FDA adverse event reports for deaths, hemorrhage, kidney failure, and stroke
The Nations Law Firm is handling Pradaxa cases. If you or someone you know has suffered a serious bleeding event after using Pradaxa, contact us for a free evaluation by one of our Pradaxa attorneys.
